Alterola Biotech, Inc.
OTC: ABTI0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- David John Hitchcock
- Employees
- 1
- Headquarters
- Birkenhead, United Kingdom
- IPO year
- 2010
- Market cap
- $7.4M
- Website
- https://alterola-abti.com
Loading ABTI…
Loading profile data…Frequently asked questions about ABTI
What does Alterola Biotech, Inc. (ABTI) do?
Alterola Biotech, Inc. is a pharmaceutical company dedicated to the research and development of cannabinoid and cannabinoid-like molecules. The firm primarily focuses on pioneering regulated pharmaceutical products for human and animal health, as well as regulated food items. Key activities also include the production of active pharmaceutical in...
Where does ABTI trade?
Alterola Biotech, Inc. (ABTI) trades on the Other OTC.
What sector is ABTI in?
Alterola Biotech, Inc. (ABTI) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Alterola Biotech, Inc.?
David John Hitchcock is the chief executive officer of Alterola Biotech, Inc. (ABTI).
Where is Alterola Biotech, Inc. headquartered?
Alterola Biotech, Inc. is headquartered in United Kingdom.
Does ABTI pay a dividend?
Alterola Biotech, Inc. (ABTI) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ABTI go public?
Alterola Biotech, Inc. (ABTI) completed its initial public offering in 2010.